GAERS and NEC rats were treated with cannabinoid 1/2 receptor agonist WIN 55,212-2 2 mg/kg and tested on the Elevated Plus-Maze
Cassar, D., Radic, M., Casarrubea, M., Crunelli, V., Di Giovanni, G. (2022). The effect of cannabinoid receptor agonist WIN 55,212-2 on anxiety-like behavior and locomotion in a genetic model of absence seizures in the elevated plus-maze. CNS NEUROSCIENCE & THERAPEUTICS [10.1111/cns.13848].
The effect of cannabinoid receptor agonist WIN 55,212-2 on anxiety-like behavior and locomotion in a genetic model of absence seizures in the elevated plus-maze
Casarrubea, MaurizioWriting – Review & Editing
;
2022-04-26
Abstract
GAERS and NEC rats were treated with cannabinoid 1/2 receptor agonist WIN 55,212-2 2 mg/kg and tested on the Elevated Plus-Maze
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
2022b - CNSNT.pdf
Solo gestori archvio
Tipologia:
Versione Editoriale
Dimensione
1.39 MB
Formato
Adobe PDF
|
1.39 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
